MRP
LLY icon

Measured Risk Portfolios’s Eli Lilly LLY Stock Holding History

Measured Risk Portfolios’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Hold
223
– – 0.22% 64
2025
Q4 		$240K Buy
+223
New +$213K 0.24% 60
2025
Q1 		– Sell
-224
Closed -$173K – 199
2024
Q4 		$173K Buy
+224
New +$185K 0.18% 64

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Measured Risk Portfolios's LLY Position: Q1 2026 in Review

Measured Risk Portfolios held its Eli Lilly (LLY) position steady in Q1 2026 at 223 shares worth $205K. The position accounts for 0.22% of the portfolio, ranked #64.

Measured Risk Portfolios first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. The position peaked at $240K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Measured Risk Portfolios held 223 shares of Eli Lilly worth $205K as of Q1 2026.
  • Measured Risk Portfolios left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.22% of Measured Risk Portfolios's portfolio in Q1 2026, its #64 holding.
  • Measured Risk Portfolios first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • Measured Risk Portfolios's Eli Lilly position peaked at $240K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Measured Risk Portfolios's 13F filing for Q1 2026, filed 15 May 2026.